| 亚胺培南/西司他丁与头孢他啶治疗中、重度细菌感染疗效费用分析比较研究 |
| |
| 引用本文： | 曲晓华,李真,戴丽.亚胺培南/西司他丁与头孢他啶治疗中、重度细菌感染疗效费用分析比较研究[J].中国抗生素杂志,1997(4). |
| |
| 作者姓名： | 曲晓华 李真 戴丽 |
| |
| 作者单位： | 北京积水潭医院 |
| |
| 摘 要： | 对我院４５例确诊为中、重度细菌感染住院患者进行了亚胺培南／西司他丁与头孢他啶疗效费用分析比较研究。结果表明：２组病例有效率、死亡率无显著性差异；头孢他啶组较亚胺培南／西司他丁组疗程明显延长。亚胺培南／西司他丁每日所需费用明显高于头孢他啶；治疗结束时，前者全部费用并未超过后者；全部住院费用无明显差异。作者认为：决定２种药物全部费用的因素，除与药物单价和每日费用有关，还与药物疗程密切相关。选用药物抗菌作用越强，用药时间即相应缩短，住院时间必然缩短；最终患者住院费用降低
|
| 关 键 词： | 亚胺培南／西司他丁 头孢他啶 疗效费用分析 细菌感染 |
Cost effectiveness analysis of imipenem/cilastatin versus ceftazidime in the treatment of moderate and severe bacterial infection |
| |
| Qu Xiaohua,Li Zhen and Dai Li.Cost effectiveness analysis of imipenem/cilastatin versus ceftazidime in the treatment of moderate and severe bacterial infection[J].Chinese Journal of Antibiotics,1997(4). |
| |
| Authors: | Qu Xiaohua Li Zhen and Dai Li |
| |
| Abstract: | Cost effectiveness analysis of imipenem/cilastatin versus ceftazidime in treatment of 45 hospicalized patients with moderate and severe bacterial infection was assessed. There is no difference in clinical efficacy and mortality rate between two groups. Ceftazidime group is longer than imipenem/cilastatin group in course of treatment. Daily cost of antibiotic in imipenem/cilastatin group exceeds that in ceftazidime group. Total cost of imipenem/cilastatin group corresponds to that of ceftazidime group. |
| |
| Keywords: | Imipenem/cilastatin Ceftazidime Cost effectiveness analysis (CEA) Bacterial infection |
| 本文献已被 CNKI 等数据库收录！ |
